Condensed Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2013	$ (173,758)	$ 1,233	$ 81,323	$ (213,038)	$ (43,276)
Common stock, shares outstanding, Beginning balance at Jan. 31, 2013	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(45,021)	0	0	0	(45,021)
Adjustment to outstanding shares per stock transfer amount	0	0	0	0	0
Adjustment to outstanding shares per stock transfer amount, shares		0
Shareholders' deficiency, Ending balance at Jul. 31, 2013	$ (218,779)	$ 1,233	$ 81,323	$ (213,038)	$ (88,297)
Common stock, shares outstanding, Ending balance at Jul. 31, 2013	1,233,853	1,233,853